Language English
The University of North Carolina at Chapel Hill ("UNC") is committed to providing notice about the Personal Information (defined below) collected via the Mom Genes Fight PPD (previously called PPD Act) research study mobile application ("App"). The formal name of the research study is the "Genomics of Postpartum Depression - Action towards Causes and Treatment," and it is organized by the PACT Consortium and sponsored by UNC (the "Study"). To participate in the Study you will be required to sign a consent to participate ("Informed Consent").
The App is an integral part of the Study. This "Mom Genes Fight PPD Privacy Policy" ("Privacy Policy") provides information about how we will collect, use, store and share Personal Information about Study participants who use the App ("you").
The App will be used in different ways for two phases of the Study:
The App is available to you for free. You will not need to provide any payment information for the use of the App.
We are not asking you to make any health decisions based on the use of the App. You should discuss health decisions directly with your healthcare provider.
The App will provide a link to this Privacy Policy. If you download or use the App, supply Personal Information or answers to questions through the App, or register for an account with us, that will be your consent to this Privacy Policy. Once you've got the App, you will be asked to sign the Informed Consent to participate in Phase I of the Study and will not be allowed to proceed in the Study unless you do sign. A copy of the Informed Consent you sign will be sent for your records to the email address you provide in the App. You can access or download a copy of this Privacy Policy by going to http://www.momgenesfightppd.org/privacy-policy/.
This Privacy Policy covers our treatment of personally identifiable information and other information that might, or might not, personally identify you and is related to the Study. For ease of reference, we will call this information "Personal Information." This Privacy Policy does not apply to other research studies or other, unrelated activities conducted at UNC or to similar studies conducted at partner universities.
The App contains links to external websites that provide resources for PPD support. This Privacy Policy does not cover, and we are not responsible for the privacy policies or practices of websites that may be accessed through these links. When following a link to another website, you should read that website's privacy policy and make sure that you agree with it.
Your use of the App will allow you to provide us with Personal Information as outlined in the Informed Consent(s) and this Privacy Policy.
The Study is designed for adult women. We do not knowingly collect or solicit Personal Information from anyone under the age of 18 and we do not wish to receive it. The Study is limited to participants who live in the United States and are 18 years old or older. In the event that we gain actual knowledge that we have collected Personal Information from a child under age 18, we will delete that information. If you are a parent or guardian and believe that we might have collected such information, please contact us using the contact information below.
The purpose of the Study is to understand genetic risks of PPD and PPP. Phase I of the Study must first identify if you are eligible to participate by asking your comfort with using the English language on your smart device, gender, age and whether you have given live birth. If you are eligible to participate and you sign the Informed Consent, the Study will collect (through the App) personally identifiable information about you such as name, address, and email address. The App will also ask you about your pregnancy history and mood following childbirth, including questions about medical history and your psychological symptoms (e.g. anxiety) in the postpartum period.
If you provide the above-described Personal Information and it is determined that you experienced PPD or PPP, you may be asked through the App and by email if you would like to participate in Phase II of the Study. As described above, Phase II involves you submitting a sample of DNA (collected from saliva you spit into a collection tube we mail to you) to help researchers determine how genes affect the development of PPD and PPP. You would be required to complete a second Informed Consent through the App to participate in Phase II. With your Informed Consent, your DNA sample will be reviewed for genetic markers (or "signposts") and re-sequenced to try to find any differences that women with PPD or PPP might have.
You may choose not to provide us with certain information. You have the chance to skip any questions in the App that make you uncomfortable, to stop participation at any point, to decline to participate in Phase II of the Study, and to withdraw from the Study completely. Though refusal to provide some Personal Information may exclude you from participation in the Study, it will not affect your relationship with the research team or UNC.
The App includes two tools that automatically collect certain information beyond that which you affirmatively provide. One tool collects information about crashes (Crashlytics) and one about use of the App (iTunes Connect). These tools work on an anonymous basis, without collecting personally identifiable information. Through these tools, the App may automatically receive anonymous technical information relating to your operating system, device, features used, content viewed and downloaded, whether crashes occurred, and the dates and times of your interactions with the App. We may internally use this information to understand, customize and generally improve user experience with the App and the Study.
Once you provide Informed Consent in the App and enroll in the Study (if eligible), you will receive push notifications regarding the Study. "Push Notifications" are messages that are sent to your smart device within the App. Push Notifications may be sent to ask you to complete questions in the Study after your initial enrollment. You will also receive Push Notifications when we update the App with new questions or features asking you to complete these tasks and surveys, and the information you provide in response will be used and treated the same as other Personal Information you might provide in Phase I of the Study.
The App will also send you Push Notifications and an email (to the email address you provide) throughout your participation in the Study, as necessary, to try and make sure that you know any new information gained during the Study that might affect your willingness to continue to participate. You can choose to receive or not receive updates about the Study and you have the option to control notification settings on your smart device (for example, to turn off any audible notification tone). Lastly, the App may send you a Push Notification and an email to invite you to participate in Phase II of the Study.
All information that is collected through the App will be encrypted through encryption methods currently used at UNC and sent to a protected data server behind UNC's firewall. If you participate in Phase II of the Study, your DNA sample and genetic data will also be stored in a protected way at UNC. (See the section below on "Sharing" for information about storage of your DNA sample and genetic data at the National Institutes of Health).
UNC will replace the direct identifiers you provide - like your name and address - with a code to help protect your identity. UNC will encrypt the direct identifiers and store them separately. Because the remaining information is coded, researchers using this information should not be readily able to identify which information pertains to you.
UNC researchers will keep your Personal Information indefinitely, except if you withdraw from the Study, in which case your Personal Information, including your DNA sample, will be destroyed from UNC's records and repository. (See the section below on "Choices" for information about removal of your de-identified DNA sample and genetic data from the National Institutes of Health repositories). The only people who will have authorized access to the code set with your individual identity are UNC study personnel, who will retain the ability to re-identify your Personal Information if doing so is needed for research integrity purposes or legal purposes. UNC may also share your re-identified Personal Information with others at UNC who need to see such information to ensure that the research meets legal, regulatory or institutional requirements.
You too can help with security. For example, access to the App on your smart device may be protected by a biometric authentication mechanism (such as Touch ID) or a passcode. You should take these or other steps to prevent unauthorized access to your smart device by protecting and limiting access to your smart device. We strongly recommend that you always use the most updated version of the operating system for your smart device. You should review the privacy and security settings often, and restrict any unnecessary access.
No matter our efforts, we cannot guarantee complete security. Unauthorized entry or use, hardware or software failure, and other factors, may compromise the security of your Personal Information.
The information collected by the App and through the DNA sampling kit will only be used for research purposes. Your name will never be used in publications or presentations when the results of the study become available.
As described above, your Personal Information will be coded. The code will be stored separately and in a protected way. The only people who will have permission to access this code will be the UNC research team. We intend that the only time your identifiable information will be shared outside of UNC is when required by law. For example, we might believe disclosure is necessary to comply with a regulatory requirement, judicial proceeding, court order, or legal process served on us, or to protect the safety, rights, or property of UNC or the public.
De-identified (coded) information about your experience with PPD or PPP, DNA, saliva, and genetic results will also be stored at a controlled repository at the U.S. National Institute of Mental Health. De-identified (coded) information about your experience with PPD or PPP and genetic results will also be stored in "dbGAaP," which is another controlled repository run by the U.S. National Institutes of Health ("NIH"). Your de-identified information may also be made available by the NIH to other qualified researchers studying genetic indicators of medical conditions, if those other researchers sign a contract with the NIH promising not to try to identify or contact you.
Through the App, you may access the following information you've provided to us: name, mailing address, and email address.
When you update information, however, we may maintain a copy of the unrevised information in our records to track the data entry into the Study. The information you can view and update may change as the App undergoes further development. Please note that any information that is automatically uploaded from the App (e.g., dates App used) cannot later be changed or updated. If you have any questions about viewing or updating information you have provided to us, please contact us using the contact information below.
You may choose not to install the App. If you choose not to install the App, you cannot participate in the Study.
If you join the Study, you can choose not to answer any question in the App that makes you feel uncomfortable or that you do not want to answer. You can also withdraw from the Study (Phase I or Phase II) at any time by emailing the UNC researchers at momgenesfightppd@med.unc.edu. When you withdraw from Phase I of the Study we will remove your Personal Information from the Study databases and, if you participated in and withdraw from Phase II of the Study, we will remove your DNA and genetic information from the UNC repository, though we may not be able to remove your de-identified information from research or publications that have already happened. If you withdraw from Phase II, we will also make efforts to remove your de-identified DNA and genetic results from the NIH repositories and ask the NIH to instruct other researchers who may have obtained controlled access to it to not include your data in their research though, again, this may not be able to affect the inclusion of your de-identified information in research that has already happened.
Once the Study is over, we may use your Personal Information to contact you in the future, sometimes just to make sure we know your contact details are still accurate, sometimes to ask if you would be willing to participate in additional research opportunities. We will probably do this a few times per year.
By downloading and using the App, you agree that you will not do anything to interfere with or disrupt the operation of the App, will provide only accurate and current information through the App, and will not impersonate anyone else in your use of the App.
You further agree not to transmit content that you do not have the right to transmit or that infringes the rights of any party, and you agree to use the App in compliance with all applicable laws. You understand that the App or portions of it may be subject to patent, copyright, trademark and other intellectual property protection and that the ownership of software and other intellectual property related to the App, as well the goodwill associated therewith, remains with UNC or its licensors. You agree that any improvements or other changes to the App or the Study itself are the sole property of UNC.
This Privacy Policy is effective as of March 21, 2016. We may amend this Privacy Policy from time to time in our good faith discretion. New versions of this Privacy Policy are effective when they are posted to our website at the following link: http://www.momgenesfightppd.org/privacy-policy/. Use of information we collect now is subject to the version of the Privacy Policy in effect at the time such information is used.
If you have any questions or concerns regarding the topics addressed in this Privacy Policy, please send a message using the contact information below.
Contact Information
Email: momgenesfightppd@med.unc.edu
Address:
Attention: PACT Study Team, c/o Dr. Meltzer-Brody
University of North Carolina at Chapel Hill
Department of Psychiatry, Campus Box #7160
Chapel Hill, NC 27599
Language English
The University of Queensland ("UQ") is committed to providing notice about the Personal Information (defined below) collected via the PPD ACT research study mobile application ("App"). The formal name of the research study is the "Genomics of Postpartum Depression - Action towards Causes and Treatment," and it is organized by the PACT Consortium and sponsored by The University of North Carolina at Chapel Hill (UNC), with UQ leading the Australian study (the "Study"). To participate in the Study you will be required to sign a consent to participate ("Informed Consent").
The App is an integral part of the Study. This "PPD ACT Privacy Policy" ("Privacy Policy") provides information about how we will collect, use, store and share Personal Information about Study participants who use the App ("you").
The App will be used in different ways for two phases of the Study:
The App is available to you for free however you may incur charges in downloading the App.
You will not need to provide any payment information for the use of the App.
We are not asking you to make any health decisions based on the use of the App. You should discuss health decisions directly with your healthcare provider.
We agree to comply with all laws and applicable codes of conduct in relation to use of the data under the Information Privacy Act 2009 (Qld).
The App will provide a link to this Privacy Policy and UQ's general terms of use including its privacy policy (http://www.uq.edu.au/terms-of-use). If you download or use the App, supply Personal Information or answers to questions through the App, or register for an account with us, that will be your consent to this Privacy Policy and the terms contained. Once you've got the App, you will be asked to sign the Informed Consent to participate in Phase I of the Study and will not be allowed to proceed in the Study unless you do sign. A copy of the Informed Consent you sign will be sent for your records to the email address you provide in the App. You can access or download a copy of this Privacy Policy by going to pactforthecure.com
This Privacy Policy covers our treatment of personally identifiable information and other information that might, or might not, personally identify you and is related to the Study and includes information or an opinion about an identified individual, or an individual who is reasonably identifiable:
The App contains links to external websites that provide resources for PPD support. This Privacy Policy does not cover, and we are not responsible for the privacy policies or practices of websites that may be accessed through these links. When following a link to another website, you should read that website's privacy policy and make sure that you agree with it.
Your use of the App will allow you to provide us with Personal Information as outlined in the Informed Consent(s) and this Privacy Policy.
The Study is designed for adult women. We do not knowingly collect or solicit Personal Information from anyone under the age of 18 and we do not wish to receive it. The Study is limited to participants who live in Australia and are 18 years old or older. In the event that we gain actual knowledge that we have collected Personal Information from a child under age 18, we will delete that information. If you are a parent or guardian and believe that we might have collected such information, please contact us using the contact information below.
The purpose of the Study is to understand genetic risks of PPD and PPP. Phase I of the Study must first identify if you are eligible to participate by asking your comfort with using the English language on your smart device, gender, age and whether you have given live birth. If you are eligible to participate and you sign the Informed Consent, the Study will collect (through the App) personally identifiable information about you such as name, address, and email address. The App will also ask you about your pregnancy history and mood following childbirth, including questions about medical history and your psychological symptoms (e.g. anxiety) in the postpartum period.
If you provide the above-described Personal Information and it is determined that you experienced PPD or PPP, you may be asked through the App and by email if you would like to participate in Phase II of the Study. Please note that in Australia, Phase II of the Study is currently under consideration.
Should Phase II proceed, Phase II involves you submitting a sample of DNA (collected from saliva you spit into a collection tube we mail to you) to help researchers determine how genes affect the development of PPD and PPP. You would be required to complete a second Informed Consent to participate in Phase II. With your Informed Consent, your DNA sample will be used to measure 500,000 or more genetic markers (or "signposts"). We would like to search for new genetic differences that women with postpartum depression and postpartum psychosis might have.
You may choose not to provide us with certain information. You have the chance to skip any questions in the App that make you uncomfortable, to stop participation at any point, to decline to participate in Phase II of the Study, and to withdraw from the Study completely. Though refusal to provide some Personal Information may exclude you from participation in the Study, it will not affect your relationship with the research team or UQ, or the wider international study.
The App includes two tools that automatically collect certain information beyond that which you affirmatively provide. One tool collects information about crashes (Crashlytics) and one about use of the App (iTunes Connect). These tools work on an anonymous basis, without collecting personally identifiable information. Through these tools, the App may automatically receive anonymous technical information relating to your operating system, device, features used, content viewed and downloaded, whether crashes occurred, and the dates and times of your interactions with the App. We may internally use this information to understand, customize and generally improve user experience with the App and the Study.
Once you provide Informed Consent in the App and enroll in the Study (if eligible), you will receive push notifications regarding the Study. "Push Notifications" are messages that are sent to your smart device within the App. Push Notifications may be sent to ask you to complete questions in the Study after your initial enrollment. You will also receive Push Notifications when we update the App with new questions or features asking you to complete these tasks and surveys, and the information you provide in response will be used and treated the same as other Personal Information you might provide in Phase I of the Study.
The App will also send you Push Notifications and an email (to the email address you provide) throughout your participation in the Study, as necessary, to try and make sure that you know any new information gained during the Study that might affect your willingness to continue to participate. You can choose to receive or not receive updates about the Study and you have the option to control notification settings on your smart device (for example, to turn off any audible notification tone). Lastly, the App may send you a Push Notification and an email to invite you to participate in Phase II of the Study.
All information that is collected through the App will be encrypted through encryption methods currently used at UNC in the United States of America and sent to a protected data server behind UNC's firewall. The encrypted data will be passed to UQ and sent to a protected data server behind UQ's firewall. The decryption key will be held by UQ and decryption of the data will be conducted at UQ. If Phase II of the Study proceeds, and if you participate in Phase II of the Study, your DNA sample and genetic data will also be stored in a protected way at UQ.
UQ will replace the personal information identifiers (or information reasonably identifiable) formation you provide - like your name and address - with a code to help protect your identity. UQ will encrypt the direct identifiers and store them separately. Because the remaining information is coded, researchers using this information should not be readily able to identify which information pertains to you.
UQ researchers will keep your Personal Information indefinitely, except if you withdraw from the Study, in which case your Personal Information, will be destroyed from UQ's records and repository. The only people who will have authorized access to the code set with your individual identity are UQ study personnel, who will retain the ability to re-identify your Personal Information if doing so is needed for research integrity purposes or legal purposes. UQ may also share your re-identified Personal Information with others at UQ who need to see such information to ensure that the research meets legal, regulatory or institutional requirements.
You too can help with security. For example, access to the App on your smart device may be protected by a biometric authentication mechanism (such as Touch ID) or a passcode. You should take these or other steps to prevent unauthorized access to your smart device by protecting and limiting access to your smart device. We strongly recommend that you always use the most updated version of the operating system for your smart device. You should review the privacy and security settings often, and restrict any unnecessary access.
No matter our efforts, we cannot guarantee complete security. Unauthorized entry or use, hardware or software failure, and other factors, may compromise the security of your Personal Information.
The information collected by the App will only be used for research purposes. Your name will never be used in publications or presentations when the results of the study become available.
As described above, your Personal Information will be coded. The code will be stored separately and in a protected way. The only people who will have permission to access this code will be the UQ research team. We intend that the only time your identifiable information will be shared outside of UQ is when required by law. For example, we might believe disclosure is necessary to comply with a regulatory requirement, judicial proceeding, court order, or legal process served on us, or to protect the safety, rights, or property of UQ or the public.
Through the App, you may access the following information you've provided to us: name, mailing address, and email address.
When you update information, however, we may maintain a copy of the unrevised information in our records to track the data entry into the Study. The information you can view and update may change as the App undergoes further development. Please note that any information that is automatically uploaded from the App (e.g., dates App used) cannot later be changed or updated. If you have any questions about viewing or updating information you have provided to us, please contact us using the contact information below.
You may choose not to install the App. If you choose not to install the App, you cannot participate in the Study.
If you join the Study, you can choose not to answer any question in the App that makes you feel uncomfortable or that you do not want to answer. You can also withdraw from the Study (Phase I or Phase II) at any time by emailing the researchers at momgenesfightppd@med.unc.edu. When you withdraw from Phase I of the Study we will remove your Personal Information from the Study databases, though we may not be able to remove your de-identified information from research or publications that have already happened.
Once the Study is over, we may use your Personal Information to contact you in the future, sometimes just to make sure we know your contact details are still accurate, sometimes to ask if you would be willing to participate in additional research opportunities, including Phase II of the study. We will probably do this a few times per year.
By downloading and using the App, you agree that you will not do anything to interfere with or disrupt the operation of the App, will provide only accurate and current information through the App, and will not impersonate anyone else in your use of the App.
You further agree not to transmit content that you do not have the right to transmit or that infringes the rights of any party, and you agree to use the App in compliance with all applicable laws. You understand that the App or portions of it may be subject to patent, copyright, trademark and other intellectual property protection and that the ownership of software and other intellectual property related to the App, as well the goodwill associated therewith, remains with UNC or its licensors. You agree that any improvements or other changes to the App or the Study itself are the sole property of UNC or its licensors.
This Privacy Policy is effective as of March 21, 2016. We may amend this Privacy Policy from time to time in our good faith discretion. New versions of this Privacy Policy are effective when they are posted to our website at the following link: http://www.momgenesfightppd.org/privacy-policy/. Use of information we collect now is subject to the version of the Privacy Policy in effect at the time such information is used.
If you have any questions or concerns regarding the topics addressed in this Privacy Policy, please send a message using the contact information below.
Contact Information
Email: momgenesfightppd@med.unc.edu
Address: Queensland Brain Institute
Attention: PPD ACT Study Team, c/o Professor Naomi Wray
The University of Queensland
Building #79
Room 432
Brisbane, 4072
Queensland, Australia
Language English
Women's College Hospital ("WCH") is committed to providing notice about the Personal Information (defined below) collected via the PPD ACT research study mobile application ("App"). The formal name of the research study in Canada is "Postpartum Depression - Action Towards Causes and Treatment: A Genetic Research Study on Postpartum Depression" and it is organized by the PACT Consortium and sponsored by Women's College Hospital (WCH), with WCH leading the Canadian study (the "Study"). To participate in the Study you will be required to sign a consent to participate ("Informed Consent").
The App is an integral part of the Study. This "PPD ACT Privacy Policy" ("Privacy Policy") provides information about how we will collect, use, store and share Personal Information about Study participants who use the App ("you").
The App will be used in different ways for two phases of the Study:
The App is available to you for free however you may incur charges in downloading the App. You will not need to provide any payment information for the use of the App.
We are not asking you to make any health decisions based on the use of the App. You should discuss health decisions directly with your healthcare provider.
The App will provide a link to this Privacy Policy. If you download or use the App, supply Personal Information or answers to questions through the App, or register for an account with us, that will be your consent to this Privacy Policy. If you agree to participate, you will agree to the study and sign the consent form directly on the app. A copy of the consent form with your digital signature will be emailed to you.
This Privacy Policy covers our treatment of personally identifiable information and other information that might, or might not, personally identify you and is related to the Study. For ease of reference, we will call this information "Personal Information." This Privacy Policy does not apply to other research studies or other, unrelated activities conducted at WCH or to similar studies conducted at partner universities.
The App contains links to external websites that provide resources for PPD support. This Privacy Policy does not cover, and we are not responsible for the privacy policies or practices of websites that may be accessed through these links. When following a link to another website, you should read that website's privacy policy and make sure that you agree with it.
Your use of the App will allow you to provide us with Personal Information as outlined in the Informed Consent(s) and this Privacy Policy.
The Study is designed for adult women. We do not knowingly collect or solicit Personal Information from anyone under the age of 18 and we do not wish to receive it. The Study is limited to participants who live in Canada and are 18 years old or older. In the event that we gain actual knowledge that we have collected Personal Information from a child under age 18, we will delete that information. If you are a parent or guardian and believe that we might have collected such information, please contact us using the contact information below.
Our goal is to understand the genetic causes of postpartum depression. To do this, we need study data from thousands of women with postpartum depression:
We will only collect the data we tell you about. We will not access data on your device like your personal contacts, other applications, phone use, text messages, photos, or websites visited. Your coded data will be used for scientific research, and may be shared with other scientific researchers. We will not share information about you with anyone that could be easily used to identify you.
Together with other participants' data, your coded study data will provide a rich database for postpartum depression research. It also provides a safe way to share the data with other researchers. We will never give your personal information or study data to a commercial third party (like an advertiser).
Your participation in this study is voluntary. You may decide not to participate. You may decide to leave the study at any time. If you withdraw from the study, we will stop collecting new data.
You may withdraw your consent and discontinue participation in this study at any time directly via the App.
The App includes two tools that automatically collect certain information beyond that which you affirmatively provide. One tool collects information about crashes (Crashlytics) and one about use of the App (iTunes Connect). These tools work on an anonymous basis, without collecting personally identifiable information. Through these tools, the App may automatically receive anonymous technical information relating to your operating system, device, features used, content viewed and downloaded, whether crashes occurred, and the dates and times of your interactions with the App. We may internally use this information to understand, customize and generally improve user experience with the App and the Study.
Once you provide Informed Consent in the App and enroll in the Study (if eligible), you will receive push notifications regarding the Study. "Push Notifications" are messages that are sent to your smart device within the App. You can keep the PPD ACT app on your phone for as long as you like. There will be ongoing updates to the app that will allow you to learn more about PPD. You can choose to receive or not to receive updates about the study. We will use the app and Push Notifications to contact you about:
If you do not want the study team to contact you, you can "opt out" from within this app. Simply change your settings in the "Profile" tab.
We will keep the information collected in this study indefinitely. This is so that we can do new and more detailed analyses over time as new information comes up about the types of questions that your information.
We take our obligation to protect your privacy very seriously. All data will be encoded to protect your identity and stored on secure servers under the control of Women's College Hospital (WCH).
There are two main things we can do to protect your privacy. First, the information that you give us that identifies you will be encrypted and stored on a secure server run by professionals at WCH to prevent improper access. Second, we will use a random code (like "FXP77TP9") to identify you when we analyze the data you share with us. These steps can greatly minimize the risk of loss of privacy. However, even with these steps, we can't promise that your privacy will be perfectly secure. You need to keep this in mind when deciding about participating in this study.
There is the very small risk that someone could get access to the personal information you provide. This could cause embarrassment. We take many steps to ensure your confidentiality, including keeping your identifiable information (such as your name and contact information) separate from the other information you provide as part of the study, and by keeping all data on secure servers. Therefore, we believe that this risk is very small.
You may withdraw your consent and discontinue participation in this study at any time. Any study data you provide prior to withdrawing your consent will remain as part of the study. If you wish for us to remove the information you already provided to us as part of the study in Part One or Part Two so that we do not use it in the analyses, you must notify us in writing, via email (pact.canada@wchospital.ca).
Our goal is to understand the genetic causes of postpartum depression. To do this, we need study data from thousands of women with postpartum depression. This data may be shared with other scientific researchers. So, all the data you share with us will be used to try to understand the causes of postpartum depression. We will combine your data with those from other women who participate in this study. In these analyses of your data, your study data will be identified by a random code (like "FXP77TP9") and not something that could be used to easily identify you.
Together with other participants' data, your coded study data will provide a rich database for postpartum depression research. It also provides a safe way to share the data with other researchers. We will never give your personal information or study data to a commercial third party (like an advertiser).
Through the App, you may access the following information you've provided to us: name, mailing address, and email address.
When you update information, however, we may maintain a copy of the unrevised information in our records to track the data entry into the Study. The information you can view and update may change as the App undergoes further development. Please note that any information that is automatically uploaded from the App (e.g., dates App used) cannot later be changed or updated. If you have any questions about viewing or updating information you have provided to us, please contact us using the contact information below.
You may choose not to install the App. If you choose not to install the App, you cannot participate in the Study. If you join the Study, you can choose not to answer any question in the App that makes you feel uncomfortable or that you do not want to answer. You may withdraw your consent and discontinue participation in this study at any time. Any study data you provide prior to withdrawing your consent will remain as part of the study. If you wish for us to remove the information you already provided to us as part of the study in Part One or Part Two so that we do not use it in the analyses, you must notify us in writing, via email (pact.canada@wchospital.ca).
We would like your permission to communicate with you in the future. We will reach out to you just to make sure we know that your contact details are still correct. We will probably do this a few times per year. We will only use your email and phone number as a way to re-contact you in addition to Push notifications. If you do not want the study team to contact you, you can "opt out" from within this app. Simply change your settings in the "Profile" tab.
By downloading and using the App, you agree that you will not do anything to interfere with or disrupt the operation of the App, will provide only accurate and current information through the App, and will not impersonate anyone else in your use of the App.
You further agree not to transmit content that you do not have the right to transmit or that infringes the rights of any party, and you agree to use the App in compliance with all applicable laws. You understand that the App or portions of it may be subject to patent, copyright, trademark and other intellectual property protection and that the ownership of software and other intellectual property related to the App, as well the goodwill associated therewith, remains with WCH or its licensors. You agree that any improvements or other changes to the App or the Study itself are the sole property of WCH.
This Privacy Policy is effective as of April 24, 2017. We may amend this Privacy Policy from time to time in our good faith discretion. New versions of this Privacy Policy are effective when they are posted to our website. Use of information we collect now is subject to the version of the Privacy Policy in effect at the time such information is used.
If there are any questions or concerns regarding the topics addressed in this Privacy Policy, please contact the study team using the contact information below.
Email: pact.canada@wchospital.ca
Address:
PACT Canada c/o Dr. Simone Vigod
Women's College Hospital
Research Institute
76 Grenville Street, 6th Floor
Toronto ON Canada M5S1B2